BE829830A - Composition pour traiter la schizophrenie - Google Patents
Composition pour traiter la schizophrenieInfo
- Publication number
- BE829830A BE829830A BE156998A BE156998A BE829830A BE 829830 A BE829830 A BE 829830A BE 156998 A BE156998 A BE 156998A BE 156998 A BE156998 A BE 156998A BE 829830 A BE829830 A BE 829830A
- Authority
- BE
- Belgium
- Prior art keywords
- composition
- treat schizophrenia
- schizophrenia
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/475,856 US3947579A (en) | 1974-06-03 | 1974-06-03 | Method and composition for potentiating neuroleptic drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
BE829830A true BE829830A (fr) | 1975-10-01 |
Family
ID=23889440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE156998A BE829830A (fr) | 1974-06-03 | 1975-06-03 | Composition pour traiter la schizophrenie |
Country Status (12)
Country | Link |
---|---|
US (1) | US3947579A (fr) |
AU (1) | AU499034B2 (fr) |
BE (1) | BE829830A (fr) |
CA (1) | CA1048932A (fr) |
DE (1) | DE2523998A1 (fr) |
FR (1) | FR2272646B1 (fr) |
GB (2) | GB1514311A (fr) |
IE (1) | IE41374B1 (fr) |
IL (1) | IL47324A (fr) |
NL (1) | NL7506404A (fr) |
PH (1) | PH13894A (fr) |
ZA (1) | ZA753316B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2453643A2 (fr) * | 1977-06-24 | 1980-11-07 | Synthelabo | Compositions pharmaceutiques actives sur le systeme nerveux central |
US4160835A (en) * | 1976-11-19 | 1979-07-10 | Merck & Co., Inc. | Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid |
NL7706429A (nl) * | 1977-06-10 | 1978-12-12 | Univ Erasmus | Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking. |
US4148896A (en) * | 1978-02-22 | 1979-04-10 | E. I. Du Pont De Nemours And Company | Antidepressant combination |
US4346085A (en) * | 1980-02-29 | 1982-08-24 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering amphetamine and choline |
NL8006135A (nl) * | 1980-11-10 | 1982-06-01 | Univ Erasmus | Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel. |
US4636494A (en) * | 1981-01-30 | 1987-01-13 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering amphetamine and choline |
DK373383A (da) | 1982-08-20 | 1984-02-21 | Midit | Fremgangsmaade til fremstilling af omega-aminosyrederivater |
US5296277A (en) * | 1992-06-26 | 1994-03-22 | Minnesota Mining And Manufacturing Company | Positionable and repositionable adhesive articles |
US5637617A (en) * | 1994-04-01 | 1997-06-10 | The Regents Of The University Of California | Methods for use of GABAa receptor GABAergic compounds |
US6833377B2 (en) | 2001-02-05 | 2004-12-21 | Gevys Pharmaceuticals Ltd. | Composition and method for potentiating drugs |
US20050192220A1 (en) * | 2001-02-05 | 2005-09-01 | Gevys Pharmaceuticas Ltd. | Composition and method for potentiating drugs |
US7544681B2 (en) | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
CN101445494A (zh) | 2001-09-27 | 2009-06-03 | 特拉维夫大学拉莫特有限公司 | 共轭的精神抑制药及其用途 |
CN101247837B (zh) * | 2005-06-07 | 2013-03-20 | 特拉维夫大学拉莫特有限公司 | 新的轭合精神活性药物的盐及其制备方法 |
CA2610838A1 (fr) * | 2005-06-07 | 2006-12-14 | Ramot At Tel Aviv University Ltd. | Nouveaux sels de medicaments psychotropes conjugues et leurs procedes de preparation |
JP5192485B2 (ja) | 2006-07-17 | 2013-05-08 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド | 向精神性薬物またはgabaアゴニストと有機酸とを含むコンジュゲート、ならびに疼痛および他のcns障害を治療するためのそれらの使用 |
US8207369B2 (en) | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
WO2009128057A2 (fr) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Produits psycho-pharmaceutiques |
WO2011070579A1 (fr) | 2009-12-09 | 2011-06-16 | Biolinerx Ltd. | Procédés d'amélioration des fonctions cognitives |
WO2012038963A1 (fr) | 2010-09-22 | 2012-03-29 | Ramot At Tel-Aviv University Ltd. | Sel d'addition d'acide d'un conjugué nortriptyline-gaba et son procédé de préparation |
US20160317477A1 (en) | 2015-04-30 | 2016-11-03 | Ovid Therapeutics Inc. | Methods of treating prader-willi syndrome |
US9351968B1 (en) | 2015-09-09 | 2016-05-31 | Ovid Therapeutics Inc | Methods of treating developmental disorders using pipradrol |
AU2017268795A1 (en) | 2016-05-26 | 2018-11-22 | Ovid Therapeutics Inc. | Methods of treating behavioral syndromes using pipradrol |
US10071083B2 (en) | 2017-02-03 | 2018-09-11 | Ovid Therapeutics Inc | Use of gaboxadol in the treatment of tinnitus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH449645A (de) * | 1963-07-09 | 1968-01-15 | Ciba Geigy | Verfahren zur Herstellung neuer Aminosäuren |
US3505451A (en) * | 1967-08-14 | 1970-04-07 | Geigy Chem Corp | Compositions and methods for alleviating schizophrenia employing one of haloperidol,trifluperidol or an acid addition salt thereof and one of desipramine,imipramine and an acid addition salt thereof |
-
1974
- 1974-06-03 US US05/475,856 patent/US3947579A/en not_active Expired - Lifetime
-
1975
- 1975-04-30 FR FR7513709A patent/FR2272646B1/fr not_active Expired
- 1975-05-16 GB GB20777/75A patent/GB1514311A/en not_active Expired
- 1975-05-16 GB GB1591/78A patent/GB1514312A/en not_active Expired
- 1975-05-20 IL IL47324A patent/IL47324A/xx unknown
- 1975-05-22 ZA ZA00753316A patent/ZA753316B/xx unknown
- 1975-05-22 AU AU81438/75A patent/AU499034B2/en not_active Expired
- 1975-05-28 CA CA75227970A patent/CA1048932A/fr not_active Expired
- 1975-05-30 NL NL7506404A patent/NL7506404A/xx not_active Application Discontinuation
- 1975-05-30 DE DE19752523998 patent/DE2523998A1/de not_active Ceased
- 1975-06-03 IE IE1237/75A patent/IE41374B1/xx unknown
- 1975-06-03 BE BE156998A patent/BE829830A/fr not_active IP Right Cessation
- 1975-06-03 PH PH17222A patent/PH13894A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU8143875A (en) | 1976-11-25 |
IE41374B1 (en) | 1979-12-19 |
GB1514312A (en) | 1978-06-14 |
GB1514311A (en) | 1978-06-14 |
IL47324A (en) | 1979-03-12 |
AU499034B2 (en) | 1979-04-05 |
CA1048932A (fr) | 1979-02-20 |
PH13894A (en) | 1980-10-27 |
ZA753316B (en) | 1976-04-28 |
US3947579A (en) | 1976-03-30 |
NL7506404A (nl) | 1975-12-05 |
IE41374L (en) | 1975-12-03 |
IL47324A0 (en) | 1975-08-31 |
FR2272646A1 (fr) | 1975-12-26 |
FR2272646B1 (fr) | 1978-11-10 |
DE2523998A1 (de) | 1975-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE829830A (fr) | Composition pour traiter la schizophrenie | |
BE824782A (fr) | Compositions pour le traitement de gingivite | |
IT1032583B (it) | Composizione antitraspirante | |
SE411047B (sv) | Bituminos komposition | |
IT1034453B (it) | Composizione detergente | |
IT1031312B (it) | Composizione detergenti | |
IT1030965B (it) | Composizione pimentarie | |
SE7509920L (sv) | Fenolhartskomposition | |
SE7601749L (sv) | Vattendispergerbar antiskumkomposition | |
BE827213A (fr) | Composition de polysocyanates | |
FR2278649A1 (fr) | Composition hydraulique | |
FR2297904A1 (fr) | Composition pour | |
SE7806517L (sv) | Insekticid komposition | |
IT1026540B (it) | Composizione refrattaria | |
BE828753A (fr) | Composition detergente | |
DK315575A (da) | Hydraulisk komposition | |
BE837701A (fr) | Composition pour la prophylaxie dentaire | |
SE7508308L (sv) | Peptidkomposition | |
BE828522A (fr) | Composition pour empecher la formation de tartre alcalin | |
IT1031570B (it) | Migliorata composizione antischiuma | |
RO83510A (fr) | Composition herbicide-liquide | |
SE7512565L (sv) | Formbar komposition | |
RO69336A (fr) | Composition herbicide sinergetique | |
JPS5132415A (ja) | Denhokokan | |
FR2280394A1 (fr) | Nouvelle composition antiseptique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: NELSON RESEARCH & DEVELOPMENT CY Effective date: 19850603 |